Skip Navigation


Brain Advance Access originally published online on September 17, 2008
Brain 2008 131(10):2536-2537; doi:10.1093/brain/awn221
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
131/10/2536    most recent
awn221v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Vincent, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vincent, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2008). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Scientific Commentary

Stiff, twitchy or wobbly—are GAD antibodies pathogenic?

Angela Vincent

Department of Clinical Neurology
University of Oxford
Oxford, UK

Correspondence to: E-mail: angela.vincent@imm.ox.ac.uk

The first 10% of the full text of this article appears below.

Over the last decade or so there has been increasing recognition of the importance of measuring antibodies to neuronal proteins in the diagnosis and management of disease. Such antibodies can be classified into two main groups. First, there are those that are markers for a disease process, such as the paraneoplastic antibodies against Hu, Yo, Ma2, but which are not thought to cause the disease. This is because their targets are cytoplasmic or nuclear proteins that are not exposed on the surface of the neurons, and because the patients do not respond to immunotherapies such as plasma exchange, intravenous immunoglobulins or corticosteroids. Moreover, the antibodies do not necessarily associate with specific . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?